Organovo Holdings Inc Share Price Nyse
Equities
US68620A1043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | 1.5M 120M | Sales 2023 | 370K 29.56M | Capitalization | 19.08M 1.52B |
---|---|---|---|---|---|
Net income 2022 | -11M -879M | Net income 2023 | -17M -1.36B | EV / Sales 2022 | 4.16 x |
Net cash position 2022 | 26.49M 2.12B | Net cash position 2023 | 14.2M 1.13B | EV / Sales 2023 | 13.2 x |
P/E ratio 2022 |
-2.86
x | P/E ratio 2023 |
-1.11
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.09% |
Managers | Title | Age | Since |
---|---|---|---|
Keith Murphy
CEO | Chief Executive Officer | 52 | 31/12/06 |
Thomas Hess
DFI | Director of Finance/CFO | 60 | 30/09/21 |
Steve Kunszabo
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Adam Stern
BRD | Director/Board Member | 60 | 31/01/12 |
Keith Murphy
CEO | Chief Executive Officer | 52 | 31/12/06 |
David Gobel
BRD | Director/Board Member | 71 | 14/09/20 |
1st Jan change | Capi. | |
---|---|---|
+12.08% | 42.68B | |
+0.67% | 42.4B | |
+46.79% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
-4.80% | 11.55B |